Participant flow

Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas · Source last updated 2016-01-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Sunitinib (Sutent®, SU11248) in Non-GIST Sarcomas

   id

   FG000

   title

   Sunitinib (Sutent®, SU11248) in Non-GIST Sarcomas

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      Patient Not treated

   2. reasons

      1. group Id

         FG000

         num Subjects

         3

      type

      Patient evaluable for toxicity only

   3. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      Patient found to be ineligible

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         53

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         48

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         5

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice